Mara V.A. Koerner

Extreme Vulnerability of IDH1 Mutant Cancers to NAD+ Depletion

Kensuke Tateishi, Hiroaki Wakimoto, A. John Iafrate et al. · Cancer Cell · 2015 · 439 citations · Full text

Genome Instability, Cancer Genomics, Extreme Vulnerability +4

Intratumoral heterogeneity and <i>TERT</i> promoter mutations in progressive/higher-grade meningiomas

Tareq A. Juratli, Christian Thiede, Mara V.A. Koerner et al. · Oncotarget · 2017 · 121 citations · Full text

Restoration of Temozolomide Sensitivity by PARP Inhibitors in Mismatch Repair Deficient Glioblastoma is Independent of Base Excision Repair

Fumi Higuchi, Hiroaki Nagashima, Jianfang Ning et al. · Clinical Cancer Research · 2020 · 110 citations

The Alkylating Chemotherapeutic Temozolomide Induces Metabolic Stress in <i>IDH1</i> -Mutant Cancers and Potentiates NAD+ Depletion–Mediated Cytotoxicity

Kensuke Tateishi, Fumi Higuchi, Julie J. Miller et al. · Cancer Research · 2017 · 92 citations · Full text

Genotype-targeted local therapy of glioma

Ganesh M. Shankar, Ameya R. Kirtane, Julie J. Miller et al. · Proceedings of the National Academy of Sciences · 2018 · 53 citations · Full text